Sermorelin 5MG

A 29-amino-acid analogue of GHRH that binds pituitary GHRH receptors to stimulate endogenous GH secretion. It mimics natural GH release patterns, offering higher physiological safety versus direct GH replacement (hydramed.com). Clinical use includes GH deficiency in children and adults, obesity-related ageing, showing measurable GH increases within minutes post‑injection and metabolic improvement after months . Side effects are mild (injection site reactions) with a short half‑life (~11 min) .

Intended for research purposes only. Not for human consumption.